RxDoctor Payments Data

Mustafa Baskaya, MD

Neurological Surgery · Madison, WINPI 1083686398

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,000 of the $23,391 with a category attached, or 85.5%. Stryker accounts for 94.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $20,865 and has fallen 99.8% since, to $36 in 2025. Among neurological surgery clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,391in general payments, 2019–2025

Across 35 payments — averaging $668.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$22K
  • Vascular Technology, Inc.$400
  • Mizuho America, Inc.$396
  • Zimmer Biomet$387
  • Medtronic$173
  • Carl Zeiss Meditec USA, Inc.$36

What the payments were for

  • Consulting fees$20,00086%
  • Speaking & faculty fees$4002%
  • Travel & lodging$1,1115%
  • Food & beverage$1,8808%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,391 in reported general payments places this provider in the 90th percentile of 133 neurological surgery providers in Wisconsin.

See all neurological surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$157,355
Medicare patients
120
Services billed
295

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone21$112

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →